A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection

Archives of Internal Medicine

Volumn 156, Issue 10, 1996, Pages 1109-1112

  Raz, Raul ^a,b   Miron, Dan ^a   Colodner, Raul ^a   Staler, Zmira ^c   Samara, Zmira ^d   Keness, Yoram ^a  

^a HAEMEK MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c CARMEL MEDICAL CENTER   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PSEUDOMONIC ACID;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL COLONIZATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INCIDENCE; INTRANASAL DRUG ADMINISTRATION; MALE; NOSE SMEAR; OINTMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; CARRIER STATE; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MUPIROCIN; NOSE; RECURRENCE; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 0029948649     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.10.1109     Document Type: Article

References (23)

1. Kirmani N, Tuazon CH, Murray HW, et al. Staphylococcus aureus carriage rates of patients receiving long-term hemodialysis. Arch Intern Med. 1987;138:1657-1659.
2. Dobkin JF, Miller MH, Steigbigel NH. Septicemia in patients on chronic hemodialysis. Ann Intern Med. 1978;88:28-33.
3. Williams RE. Healthy carriage of Staphylococcus aureus: its prevalence and importance. Bacteriol Rev. 1963;27:56-71.
4. Armstrong ECA, Smith JE. Carriage patterns of Staphylococcus aureus in a healthy non-hospital population of adults and children. Ann Hum Biol. 1976; 3:221-227.
5. Weinstein HJ. The relationship between the nasal staphylococcal carrier state and the incidence of post-operative complications. N Engl J Med. 1959;260: 1303-1306.
6. Wheat LJ, Kohler RB, White A. Prevention of infections of skin and skin structures. Am J Med. 1984;76:187-190.
7. Chow JW, Yu VL. Staphylococcus aureus nasal carriage in hemodialysis patients: its role in infection and approaches to prophylaxis. Arch Intern Med. 1989;149:1258-1262.
8. Yu VL, Goetz A, Wagener M, Smith PB, Rihs JD, Hanchett J. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis: efficacy of antibiotic prophylaxis. N Engl J Med. 1986;315:91-96.
9. Casewell MW, Hill RL. Mupirocin ('pseudomonic acid') - a promising new topical antimicrobial agent. J Antimicrob Chemother. 1987;19:1-5.
10. Boelaert JR, De Smedt RA, De Baere YA, Godard CA, Matthys EG. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in haemodialysis patients. Nephrol Dial Transplant. 1989;4: 278-281.
11. Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intra-nasal application of mupirocin calcium ointment. Ann Intern Med. 1991;114:101-106.
12. Casewell MW, Hill RL. Elimination of nasal carriage of Staphylococcus aureus with mupirocin ('pseudomonic acid') - a controlled trial. J Antimicrob Chemother. 1986;17:365-372.
13. Tulloch LG. Nasal carriage in staphylococcal skin infections. BMJ. 1954;2:912-913.
14. Solberg CO. A study of carriers of Staphylococcus aureus with special regard to quantitative bacterial estimations. Acta Med Scand Suppl. 1965;436:1-96.
15. White A. Increased infection rates in healthy nasal carriers of coagulase-positive staphylococci. Antimicrob Agents Chemother. 1963;3:667-670.
16. Weinstein HJ. The relation between the nasal-staphylococcal-carrier state and the incidence of postoperative complications. N Engl J Med. 1969;260:1303-1308.
17. Nahmias AJ, Shulman J. Epidemiology of staphylococci. In: Cohen JO, ed. The Staphylococci. New York, NY: John Wiley & Sons Inc; 1972:486-502.
18. Wheat LJ, Kohler RB, White A. Prevention of infection of skin and skin structures. Am J Med. 1984;76:187-190.
19. Wheat LJ, Kohler RB, White AL, et al. Effect of rifampin on nasal carriers of coagulase-positive staphylococci. J Infect Dis. 1981;144:117.
20. Klempner MS, Styrt B. Prevention of recurrent staphylococcal skin infection with low-dose oral clindamycin therapy. JAMA. 1988;260:2682-2685.
21. Tuazon C. Skin and skin structure infections in the patients at risk: carrier state of Staphylococcus aureus. Am J Med. 1984;76(5A):166-171.
22. Gilbart J, Perry CR, Slocombe B. High-level mupirocin resistance in Staphylococcus aureus: evidence for two distinct isoleucyl-tRNA synthetases. Antimicrob Agents Chemother. 1993;37:32-38.
23. Doebbeling BN, Reagan DR, Pfaller MA, Houston AK, Hollis RJ, Wenzel RP. Long term efficacy of intranasal mupirocin ointment. Arch Intern Med. 1994; 154:1505-1507.